RecruitingNot Applicable

Collection of Biological Samples From Patients With Rare Neurological Diseases

France1,000 participantsStarted 2020-10-12

Plain-language summary

The aim of this project is to improve biological collections of patients presenting rare neurological disorders with known or suspected autoimmune origin. This collection will provide appropriate biological samples to identify new biomarkers and to be accessible to the medical, scientific and industrial communities for the identification of new therapeutic strategies.

Who can participate

Age range6 Years – 99 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * all patients with neurological disorders, with known or probable autoimmune involvement. This includes adults and children and peripheral and/or central nervous system symptoms. * Social coverage up to date. Exclusion Criteria: * Patients with neurological damage from which the autoimmune character can be excluded. * Known anemia and hemoglobin \<10 g / dl * Patients under protective supervision (guardianship, curators) * Pregnant or breastfeeding woman

What they're measuring

Building a collection of biological samples and clinical-biological data from patients with rare autoimmune neurological diseases

Timeframe: Day 0 and through study completion, an average of 1 year

Trial details

NCT IDNCT04698421

SponsorUniversity Hospital, Toulouse

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2030-01-01

Contact for this trial

Chloé Bost, PharmD, PhD

5 61 77 61 44 bost.c@chu-toulouse.fr

View on ClinicalTrials.gov More Nervous System Diseases trials